MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors. - Wikidata - wikimedia - TriplyDB

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.

http://www.wikidata.org/entity/Q34245409

about

Clinical application of adoptive T cell therapy in solid tumors Engineered T cells for cancer treatment Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma.CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptor Targeting c-MYC with T-cells Codon optimization of the human papillomavirus E7 oncogene induces a CD8+ T cell response to a cryptic epitope not harbored by wild-type E7 Survivin-specific T cell receptor targets tumor but not T cells.Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy.T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells Thymic expression of a T-cell receptor targeting a tumor-associated antigen coexpressed in the thymus induces T-ALL Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy.Immunotherapy targets in pediatric cancer.A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies Generation of CD20-specific TCRs for TCR gene therapy of CD20low B-cell malignancies insusceptible to CD20-targeting antibodies.Is it time to abandon RHAMM/HMMR as a candidate antigen for immunotherapy of acute myeloid leukemia?RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediated hematopoietic stem cell toxicity.Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation.Can immunotherapy specifically target acute myeloid leukemic stem cells?Chimeric NKG2D CAR-expressing T cell-mediated attack of human ovarian cancer is enhanced by histone deacetylase inhibition.Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA Alloreactive cytotoxic T cells provide means to decipher the immunopeptidome and reveal a plethora of tumor-associated self-epitopes.Is cancer gene therapy an empty suit?Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens.Challenges in T cell receptor gene therapy.Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.Peptide-based vaccination and induction of CD8+ T-cell responses against tumor antigens in breast cancer.Tools to define the melanoma-associated immunopeptidome.Antigen processing and immune regulation in the response to tumours.Immunomodulatory monoclonal antibodies combined with peptide vaccination provide potent immunotherapy in an aggressive murine neuroblastoma model.NY-ESO-1 antigen-reactive T cell receptors exhibit diverse therapeutic capability.Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine.Exploring dendritic cell based vaccines targeting survivin for the treatment of head and neck cancer patients.Characterization of T-cell responses against IκBα in cancer patients.Dendritic cell vaccines targeting survivin in head and neck cancer.A Dynamic Model of Immune Responses to Antigen Presentation Predicts Different Regions of Tumor or Pathogen Elimination.Treating hematological malignancies with cell therapy: where are we now?Systematic identification of cancer-specific MHC-binding peptides with RAVEN

P2860

Q27011283-D773CB7A-58DF-42B4-AC91-1F413D921F0D Q33578792-B2714EF2-B175-4E9C-A245-FD15787BB590 Q34018782-0EE5D3E1-042C-4DC0-96EA-60655F5A9CF2 Q34981606-CBAB01F7-72B9-4E85-A812-56BF6DAD48E3 Q35018846-4B5A5E45-5E55-41B2-84D7-EE45E6EC1EDA Q35208290-4B785543-E8D6-4707-8B0F-5077B44FBAAF Q35242576-C38F1CCC-D517-42D7-B85E-5AF174775B2F Q35506253-5114E7B8-5E85-4567-8D04-A078A66F607D Q35533181-D08DF351-6BC8-4312-A415-43FE119B3602 Q35583414-CEBF8203-CEB1-4E7B-B2A1-55045B9F469B Q35820674-B18154FF-26E2-4743-B6CF-0D6FA49ACB08 Q35971029-3B41B8F6-1EE6-4D0B-A1FA-7A6EECE4FE0E Q35976599-E4668AF7-B775-41BB-8221-BCC0DB7FCFA1 Q36173272-80ED8FBE-DDD9-44C9-9FCE-296B4C9BDF2B Q36366928-52A5C664-DC6A-41AD-B6BE-DD5B0CF5CBD9 Q36366953-89141A9C-5C19-4020-9E53-26721CCA7AAD Q36643631-460E9F8B-DB21-4919-957D-D6D65A5F0962 Q36662079-66CC003E-8FF9-4F62-81F8-B17745A80135 Q36694901-460CFB9E-CE79-46AF-9DDD-C534166D49F5 Q36720681-874BB3D7-9F6E-47EA-BF56-8F6862235453 Q36915675-464704A3-98A1-4B72-A263-CDD96A597F7A Q37012701-85BCBDCC-EE39-4506-91F9-8DFEA2736419 Q37475195-906183D2-FAF3-41D4-9C62-C02B566D4495 Q37564361-037B4B3E-B240-465D-ABD9-4CDB5AB6F840 Q37636670-4DED795A-D9C3-47F4-A07B-280E9BF63B96 Q38011650-981EF9BC-FD35-40E3-8326-91B06D60082F Q38015123-638C951E-863C-4E15-B11A-750CFDFE7E3D Q38293525-40E78B9B-AF5C-470E-865D-2F93D3242D81 Q38650013-932156B3-D4FA-4C21-8809-502FF11490C4 Q38818628-E9E54A74-A7CA-4C78-B915-2CC99FECCAD7 Q39155565-AD719F2C-ED3D-445A-B0B0-D0CE111E017E Q39294181-C0812E6C-88BC-4C12-AD68-47E9AE4DD948 Q39546197-03F34610-C237-4DB4-B7A0-63250324C3B9 Q41503180-2C2C50B5-B457-4700-A6CF-B2D51510F538 Q42403177-BFFFF819-5209-48C2-B795-38A556DC9BE0 Q44567444-92F215E0-3E17-41C6-8F1F-6B9FDA685F0E Q47992798-1EC21CD6-6128-4C4F-89C2-049AD0B12034 Q48640926-998DE714-8CF4-45FF-894F-75D89FB71AED Q56875164-29877F59-FF1D-418C-909B-0901E48DB721

P2860

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors.

http://www.wikidata.org/entity/Q34245409

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@ast

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@en

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@nl

type

label

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@ast

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@en

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@nl

prefLabel

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@ast

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@en

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@nl

P1433

Q34245409-D166E5E0-9547-4CDF-93F4-377542E09E83

P1476

Q34245409-B025D709-B19F-4EE0-A4B8-B699A9C74298

P2093

Q34245409-0F3FBB28-C37C-4795-907C-4A153C84051B

Q34245409-0FC8AC20-1B61-47AB-883A-C835B2EFB8A7

Q34245409-1E66D31B-0718-47C1-ABF5-D818ADBA158A

Q34245409-324F70D5-E8E1-4C1F-A197-90A1395911BE

Q34245409-56C3B045-3C99-4D36-A271-543BD23E9BCF

Q34245409-C0D7807D-0C49-4D91-B159-A6B5E7D8D2F3

Q34245409-EC7EE79A-F099-4344-BECD-775C707C7B16

P2860

Q34245409-080D770B-726B-49A4-B0A8-57CA09CBA017

Q34245409-1DECE806-7A2A-4913-9490-9641130D86F9

Q34245409-29BD60FA-7F76-4042-ADD8-62F00F125D72

Q34245409-379BD207-7E3F-47B2-86C0-1C23AEAAA94B

Q34245409-3C93DA80-F106-4065-BC26-CB09D2C80796

Q34245409-45122AC7-42F2-4166-9194-8AAAFED8CFAE

Q34245409-4B66A797-F9BE-4D6E-AD65-E908D66734F9

Q34245409-4D369150-C5F1-4F54-AC43-3750FEA82CA0

Q34245409-5B6B54AD-5EC1-41A3-9909-DB3EF6B2E83E

Q34245409-5CCCB7A4-D344-4B6F-8437-2F2801EDFEB7

P304

Q34245409-2D093B1C-4AA7-43EC-B762-CB27ED3DC4FC

P31

Q34245409-F098E97A-D760-4A60-826B-B9B02B6D29BC

P356

Q34245409-20E49928-250E-4124-B859-8A7A84897A47

P407

Q34245409-804C8E0F-EEDA-4FAE-AF22-96A2DDF02F08

P433

Q34245409-E9079E49-AC8D-4C93-B201-2D2810AAAB8B

P478

Q34245409-5FFA056E-579F-4A5E-A307-9D781CE28703

P577

Q34245409-64322781-364D-4A12-99E9-C8CDB8696B88

P698

Q34245409-60842330-A711-41DD-A6EA-9FB8A83CF9E9

P932

Q34245409-DF0551A3-424A-47E5-BED1-6CCF67A878C4

P356

P1433

Journal of Clinical Investigation

P1476

MHC-restricted fratricide of h ...... c transgenic T cell receptors.

@en

P2093

Bernhard Frankenberger

http://www.w3.org/2001/XMLSchema#string

Dolores J Schendel

http://www.w3.org/2001/XMLSchema#string

Matthias Leisegang

http://www.w3.org/2001/XMLSchema#string

Slavoljub Milosevic

http://www.w3.org/2001/XMLSchema#string

Stefani Spranger

http://www.w3.org/2001/XMLSchema#string

Susanne Wilde

http://www.w3.org/2001/XMLSchema#string

Wolfgang Uckert

http://www.w3.org/2001/XMLSchema#string

P2860

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Adoptive T cell therapy for cancer in the clinic

Validating survivin as a cancer therapeutic target

Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics

Cognate peptides induce self-destruction of CD8+ cytolytic T lymphocytes

Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells

T-cell-receptor gene therapy.

The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.

P304

3869-3877

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI43437

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20978348

http://www.w3.org/2001/XMLSchema#string

P932

2964986

http://www.w3.org/2001/XMLSchema#string